Apolipoprotein E4 suppresses delayed-rectifier potassium channels in membrane patches excised from hippocampal neurons

Synapse

Volumn 59, Issue 2, 2006, Pages 82-91

  Qin, Ying ^a   Qi, Jin Shun ^a   Qiao, Jian Tian ^a  

^a SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Apolipoprotein A; Inside out membrane patch; Rats; Single channel activities

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN E4; POTASSIUM CHANNEL;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HIPPOCAMPUS; NERVE CELL MEMBRANE; NONHUMAN; PATHOGENESIS; POTASSIUM CURRENT; PRIORITY JOURNAL; RAT; VOLTAGE CLAMP;

ANIMALS; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CELL MEMBRANE; CELLS, CULTURED; DELAYED RECTIFIER POTASSIUM CHANNELS; HIPPOCAMPUS; NEURONS; PATCH-CLAMP TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 30144439887     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.20201     Document Type: Article

References (65)

1. Angulo E, Noe V, Casado V, Mallol J, Gomez-Isla T, Lluis C, Ferrer I, Ciudad CJ, Franco R. 2004. Up-regulation of the Kv3.4 potassium channel subunit in early stages of Alzheimer's disease. J Neurochem 91:547-557.
2. Arias E, Ales E, Gabilan NH, Cano-Abad MF, Villarroya M, Garcia AG, Lopez MG. 2004. Galantamine prevents apoptosis induced by β-amyloid and thapsigargin: involvement of nicotinic acetylcholine receptors. Neuropharmacology 46:103-114.
3. Carter DB. 2005. The interaction of amyloid-β with ApoE. Subcell Biochem 38:255-272.
4. Chi X, Sutton ET, Hellermann G, Price JM. 2000. Potassium channel openers prevent δ-amyloid toxicity in bovine vascular endothelial cells. Neurosci Lett 290:9-12.
5. Choi DW. 1985. Glutamate neurotoxicity in cortical cell culture is calcium dependent. Neurosci Lett 58:293-297.
6. Choi DW. 1987. Ionic dependence of glutamate neurotoxicity. J Neurosci 7:369-379.
7. Choi DW. 1988. Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci 11:465-469.
8. Choi DW. 1995. Calcium: still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci 18:58-60.
9. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA. 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261:921-923.
10. Dodart JC, Marr RA, Koistinaho M, Gregersen BM, Malkani S, Verma IM, Paul SM. 2005. Gene delivery of human apolipoprotein E alters brain Abeta burden in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 102:1211-1216.
11. Etcheberrigaray R, Ito E, Oka K, Tofel-Grehl B, Gibson GE, Alkon DL. 1993. Potassium channel dysfunction in fibroblasts identifies patients with Alzheimer disease. Proc Natl Acad Sci USA 90:8209-8213.
12. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM. 1997. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278:1349-1356.
13. Gelman BB, Rifai N, Christenson RH, Silverman LM. 1988. Cerebrospinal fluid and plasma apolipoproteins in patients with multiple sclerosis. Ann Clin Lab Sci 18:46-52.
14. Ghosh A, Greenberg ME. 1995. Calcium signaling in neurons: molecular mechanisms and cellular consequences. Science 268:239-247.
15. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Rogues P, Talbot C, Pericak-Vance M, Roses A, Williamson R, Rossor M, Owen M. 1991. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349:704-706.
16. Goedert M, Klug A. 1999. Tau protein and the paired helical filament of Alzheimer's disease. Brain Res Bull 50:469-470.
17. Goodman Y, Mattson MP. 1996. Ceramide protects hippocampal neurons against excitotoxic and oxidative insults, and amyloid β-peptide toxicity. J Neurochem 66:869-872.
18. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. 1981. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 391:85-100.
19. Harris FM, Brecht WJ, Xu Q, Mahley RW, Huang Y. 2004. Increased tau phosphorylation in apolipoprotein E4 transgenic mice is associated with activation of extracellular signal-regulated kinase: modulation by zinc. J Biol Chem 279:44795-44801.
20. Herz J, Beffert U. 2000. Apolipoprotein E receptors: linking brain development and Alzheimer's disease. Nat Rev Neurosci 1:51-58.
21. Holtzman DM, Bales KR, Tenkova T, Fagan AM, Parsadanian M, Sartorius LJ, Mackey B, Olney J, McKeel D, Wozniak D, Paul SM. 2000. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 97:2892-2897.
22. Huang Y, Liu XQ, Wyss-Coray T, Brecht WJ, Sanan DA, Mahley RW. 2001. Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons. Proc Natl Acad Sci USA 98:8838-8843.
23. Hyman BT, Van Horsen GW, Damasio AR, Barnes CL. 1984. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 225:1168-1170.
24. Hyman BT, Van Hoesen GW, Kromer LJ, Damasio AR. 1986. Perforant pathway changes and the memory impairment of Alzheimer's disease. Ann Neurol 20:472-481.
25. Irizarry MC, Cheung BS, Rebeck GW, Paul SM, Bales KR, Hyman BT. 2000. Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid β-peptide deposition in homozygous APP(V717F) transgenic mice. Acta Neuropathol (Berl) 100:451-458.
26. Jhamandas JH, Cho C, Jassar B, Harris K, MacTavish D, Easaw J. 2001. Cellular mechanisms for amyloid beta-protein activation of rat cholinergic basal forebrain neurons. J Neurophysiol 86:1312-1320.
27. Jordan J, Galindo MF, Miller RJ, Reardon CA, Getz GS, LaDu MJ. 1998. Isoform-specific effect of apolipoprotein E on cell survival and beta-amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures. J Neurosci 18:195-204.
28. Katzman R. 1986. Alzheimer's disease. N Engl J Med 314:964-973.
29. Kay AR, Wong RK. 1986. Isolation of neurons suitable for patch-clamping from adult mammalian central nervous systems. J Neurosci Methods 16:227-238.
30. Kraliz D, Singh S. 1997. Selective blockade of the delayed rectifier potassium current by tacrine in Drosophila. J Neurobiol 32:1-10.
31. +) channels. Bull Exp Biol Med 132:1079-1083.
32. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, Yu CE, Jondro PD, Schmidt SD, Wang K, Crowley AC, Fu YH, Guenette SY, Galas D, Nemens E, Wijsman EM, Bird TD, Schellenberg GD, Tanzi RE. 1995. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269:973-977.
33. Ljungberg MC, Dayanandan R, Asuni A, Rupniak TH, Anderton BH, Lovestone S. 2002. Truncated apoE forms tangle-like structures in a neuronal cell line. Neuroreport 13:867-870.
34. Ma J, Yee A, Brewer HB, Jr., Das S, Potter H. 1994. Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature 372 (6501):92-94.
35. Mahley RW. 1988. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240:622-630.
36. Mahley RW, Rail SC, Jr. 2000. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 1:507-537.
37. Mattson MP, LaFerla FM, Chan SL, Leissring MA, Shepel PN, Geiger JD. 2000. Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders. Trends Neurosci 23:222-229.
38. Miyata M, Smith JD. 1996. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and β-amyloid peptides. Nat Genet 14:55-61.
39. +-channel. Brain Pathol 8:641-653.
40. Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K. 1991. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 541:163-166.
41. Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley RW, Pitas RE. 1994. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 264:850-852.
42. Nathan BP, Chang KC, Bellosta S, Brisch E, Ge N, Mahley RW, Pitas RE. 1995. The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization. J Biol Chem 270:19791-19799.
43. Olaisen B, Teisberg P, Gedde-Dahl T, Jr. 1982. The locus for apolipoprotein E (apoE) is linked to the complement component C3 (C3) locus on chromosome 19 in man. Hum Genet 62:233-236.
44. Pitas RE, Boyles JK, Lee SH, Hui D, Weisgraber KH. 1987. Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B, E(LDL) receptors in the brain. J Biol Chem 262:14352-14360.
45. Qi JS, Qiao JT. 2001a. Amyloid β-protein fragment 31-35 forms ion channels in membrane patches excised from rat hippocampal neurons. Neuroscience 105:845-852.
46. + channels by amyloid β-protein fragment 31-35 in membrane patches excised from hippocampal neurons. Sheng Li Xue Bao 53:198-204.
47. Qi JS, Ye L, Qiao JT. 2004. Amyloid beta-protein fragment 31-35 suppresses delayed rectifying potassium channels in membrane patches excised from hippocampal neurons in rats. Synapse 51:165-172.
48. Qiu Z, Crutcher KA, Hyman BT, Rebeck GW. 2003. ApoE isoforms affect neuronal N-methyl-D-aspartate calcium responses and toxicity via receptor-mediated processes. Neuroscience 122:291-303.
49. Rogawski MA. 1986. Single voltage-dependent potassium channels in cultured rat hippocampal neurons. J Neurophysiol 56:481-493.
50. Schanne FA, Kane AB, Young EE, Farber JL. 1979. Calcium dependence of toxic cell death: a final common pathway. Science 206:700-702.
51. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, Tsuda T, Mar L, Foncin JF, Bruni AC, Montesi MP, Sorbi S, Rainero I, Pinessi L, Nee L, Chumakov I, Pollen D, Brookes A, Sanseau P, Polinsky RJ, Wasco W, Da Silva HAR, Haines JL, Pericak-Vance MA, Tanzi RE, Roses AD, Fraser PE, Rommens JM, St George-Hyslop PH. 1995. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375:754-760.
52. Storm JF. 1990. Potassium currents in hippocampal pyramidal cells. Prog Brain Res 83:161-187.
53. Strittmatter WJ, Weisgraber KH, Huang DY, Dong LM, Salvesen GS, Pericak-Vance M, Schmechel D, Saunders AM, Goldgaber D, Roses AD. 1993. Binding of human apolipoprotein E to synthetic amyloid βpeptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci USA 90:8098-8102.
54. Tanzi RE, Bertram L. 2001. New frontiers in Alzheimer's disease genetics. Neuron 32:181-184.
55. Tiraboschi P, Hansen LA, Masliah E, Alford M, Thal LJ, Corey-Bloom J. 2004. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease. Neurology 62:1977-1983.
56. Tolar M, Marques MA, Harmony JA, Crutcher KA. 1997. Neurotoxicity of the 22 kDa thrombin-cleavage fragment of apolipoprotein E and related synthetic peptides is receptor-mediated. J Neurosci 17:5678-5686.
57. Tymianski M. 1996. Cytosolic calcium concentrations and cell death in vitro. Adv Neurol 71:85-105.
58. Veeranna, Kaji T, Boland B, Odrljin T, Mohan P, Basavarajappa BS, Peterhoff C, Cataldo A, Rudnicki A, Amin N, Li BS, Pant HC, Hungund BL, Arancio O, Nixon RA. 2004. Calpain mediates calcium-induced activation of the erkl,2 MAPK pathway and cytoskeletal phosphorylation in neurons: relevance to Alzheimer's disease. Am J Pathol 165:795-805.
59. Veinbergs I, Everson A, Sagara Y, Masliah E. 2002. Neurotoxic effects of apolipoprotein E4 are mediated via dysregulation of calcium homeostasis. J Neurosci Res 67:379-387.
60. Wang XS, Gruenstein E. 1997. Rapid elevation of neuronal cytoplasmic calcium by apolipoprotein E peptide. J Cell Physiol 173:73-83.
61. Wang YJ, Chen GH, Hu XY, Lu YP, Zhou JN, Liu RY. 2005. The expression of calcium/calmodulin-dependent protein kinase II-alpha in the hippocampus of patients with Alzheimer's disease and its links with AD-related pathology. Brain Res 1031:101-108.
62. Wisniewski T, Frangione B. 1992. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 135:235-238.
63. Wisniewski T, Golabek AA, Kida E, Wisniewski KE, Frangione B. 1995. Conformational mimicry in Alzheimer's disease. Role of apolipoproteins in amyloidogenesis. Am J Pathol 147:238-244.
64. Yao J, Petanceska SS, Montine TJ, Holtzman DM, Schmidt SD, Parker CA, Callahan MJ, Lipinski WJ, Bisgaier CL, Turner BA, Nixon RA, Martins RN, Ouimet C, Smith JD, Davies P, Laska E, Ehrlich ME, Walker LC, Mathews PM, Gandy S. 2004. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Aβpeptides and F-isoprostanes in the absence of detectable amyloid deposits. J Neurochem 90:1011-1018.
65. - currents in neocortical cultures. Neurobiol Dis 13:177-190.